| Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma SS Neelapu, FL Locke, NL Bartlett, LJ Lekakis, DB Miklos, CA Jacobson, ... New England Journal of Medicine 377 (26), 2531-2544, 2017 | 4809 | 2017 |
| Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial FL Locke, A Ghobadi, CA Jacobson, DB Miklos, LJ Lekakis, OO Oluwole, ... The lancet oncology 20 (1), 31-42, 2019 | 1884 | 2019 |
| A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation JL Goodman, DJ Winston, RA Greenfield, PH Chandrasekar, B Fox, ... New England Journal of Medicine 326 (13), 845-851, 1992 | 1417 | 1992 |
| Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever TJ Walsh, P Pappas, DJ Winston, HM Lazarus, F Petersen, J Raffalli, ... New England Journal of Medicine 346 (4), 225-234, 2002 | 1226 | 2002 |
| Palifermin for oral mucositis after intensive therapy for hematologic cancers R Spielberger, P Stiff, W Bensinger, T Gentile, D Weisdorf, T Kewalramani, ... New England Journal of Medicine 351 (25), 2590-2598, 2004 | 1107 | 2004 |
| Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma JF DiPersio, EA Stadtmauer, A Nademanee, INM Micallef, PJ Stiff, ... Blood, The Journal of the American Society of Hematology 113 (23), 5720-5726, 2009 | 864 | 2009 |
| Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a … CH Moskowitz, A Nademanee, T Masszi, E Agura, J Holowiecki, MH Abidi, ... The Lancet 385 (9980), 1853-1862, 2015 | 840 | 2015 |
| Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony … JF DiPersio, IN Micallef, PJ Stiff, BJ Bolwell, RT Maziarz, E Jacobsen, ... Journal of Clinical Oncology 27 (28), 4767-4773, 2009 | 740 | 2009 |
| A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia SH Petersdorf, KJ Kopecky, M Slovak, C Willman, T Nevill, J Brandwein, ... Blood, The Journal of the American Society of Hematology 121 (24), 4854-4860, 2013 | 688 | 2013 |
| Randomized phase Ib/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer DVT Catenacci, MR Junttila, T Karrison, N Bahary, MN Horiba, SR Nattam, ... Journal of Clinical Oncology 33 (36), 4284, 2015 | 507 | 2015 |
| KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study BD Shah, A Ghobadi, OO Oluwole, AC Logan, N Boissel, RD Cassaday, ... The Lancet 398 (10299), 491-502, 2021 | 424 | 2021 |
| Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma PJ Stiff, JM Unger, JR Cook, LS Constine, S Couban, DA Stewart, ... New England Journal of Medicine 369 (18), 1681-1690, 2013 | 407 | 2013 |
| Management of the adverse effects associated with intravenous bisphosphonates T Tanvetyanon, PJ Stiff Annals of Oncology 17 (6), 897-907, 2006 | 392 | 2006 |
| Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era AM Evens, KA David, I Helenowski, B Nelson, D Kaufman, SM Kircher, ... Journal of Clinical Oncology 28 (6), 1038, 2010 | 348 | 2010 |
| Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated … LI Gordon, F Hong, RI Fisher, NL Bartlett, JM Connors, RD Gascoyne, ... Journal of Clinical Oncology 31 (6), 684, 2013 | 335 | 2013 |
| Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche CC Hofmeister, J Zhang, KL Knight, P Le, PJ Stiff Bone marrow transplantation 39 (1), 11-23, 2007 | 315 | 2007 |
| Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment ME Horwitz, NJ Chao, DA Rizzieri, GD Long, KM Sullivan, C Gasparetto, ... The Journal of clinical investigation 124 (7), 3121-3128, 2014 | 300 | 2014 |
| Prospective, randomized, double-blind, phase III clinical trial of anti–T-lymphocyte globulin to assess impact on chronic graft-versus-host disease–free survival in patients … RJ Soiffer, HT Kim, J McGuirk, ME Horwitz, L Johnston, MM Patnaik, ... Journal of Clinical Oncology 35 (36), 4003, 2017 | 281 | 2017 |
| Autologous transplantation for diffuse aggressive non-Hodgkin’s lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry JM Vose, MJ Zhang, PA Rowlings, HM Lazarus, BJ Bolwell, CO Freytes, ... Journal of Clinical Oncology 19 (2), 406-413, 2001 | 273 | 2001 |
| Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma … AK Stewart, R Vescio, G Schiller, O Ballester, S Noga, H Rugo, C Freytes, ... Journal of Clinical Oncology 19 (17), 3771-3779, 2001 | 257 | 2001 |
